We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...

Biotech company Biogen (NASDAQ:BIIB) in Q1 CY2025, with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of ...

You should learn about the 2 possible red flags we've spotted with Biogen. NasdaqGS:BIIB Revenue & Expenses Breakdown as at May 2025 Uncover 16 companies that survived and thrived after COVID and ...

Biogen Inc (NASDAQ:BIIB) reported a strong start to the year with a significant increase in revenue from new product launches, contributing to 45% of product revenue. The company received FDA Fast ...

Members of Congress have traded $BIIB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales. Here’s a breakdown of recent ...

Good morning. My name is Melinda, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Biogen First Quarter 2025 Earnings Call and Business Update. All ...

Shares of NASDAQ BIIB opened at $116.92 on Monday. Biogen has a 1 year low of $110.04 and a 1 year high of $238.00. The company has a market capitalization of $17.11 billion, a P/E ratio of 10.45 ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the June 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

Visit a quote page and your recently viewed tickers will be displayed here. Mr. Hawkins is the retired Chairman and CEO of Medtronic and has had a long and distinguished career in the Medical Devices ...